Yes, but JNJ also owns a Congressman or two and INO can't spend money like that yet.
Ok, it's beautiful, wonderful, bright and shiny, and all parts are available in quantity. So where are the contracts, the leaks, the PR's? Everybody has a patent with MVIS stated and all parts are there, help me understand what Tokmans' doing for us. I see what you see and trust what you guys and gals are saying as eye witnesses to be true and I can't figure out why he can't bring home the bacon.
Fifty bigs interested last year and five red hot prospects and we have only one component contract that I can't connect to a customer....yet. Running out of money, again, and we have nothing to look at other than a competitor entering the marked with RR/JAG, which we thought was sure to be MVIS.
Waiting for a quarterly CC that isn't even scheduled yet that they could of done October 2nd without much prep on their part.
Six long years of comments indicating success is at hand, and every big name mentioned to hold our attention and spur more buying and we can't even get a good hold on where we are in getting a product to market and who will be delivering it. Sony and UPS is what we have to hold on to as we move forward as the only concrete evidence that someone can make it work and make money with it. Staying for the end, but after all this time I should feel a lot better than I do about the CEO and the BOD and their abilities in bringing this to a profitable conclusion. One successful product and the patents will be worth a few bucks. Did I miss anything?
Maybe it's just me getting old, but Tokman and the BOD seem a lot heavier lately carrying them around. Think I'ld be accustomed to their weight after all these years, must be age.
Not going to handicap this thing, fools bet. Tokman is Tokman and yes, as stated below, everything seems so hard for him. Tech will survive I'm sure, not sure about anything else though. Reasonable to assume a contract by years end. Hoping for something good.
Well, you have the participants correct, but maybe the other way around. The way you've stated it shareholders would never stand for that much dilution.
That's it in a nut shell bourbon, you have to prove what you have. More participation by big Pharma or Peer Review, followed by data. Anyone of the three gives us credibility. Knowing what we have is Ok, but letting the world see it is another. All the conferences they are doing is just getting the word out to industry professionals and such and doesn't relate to the pps.
We need income from now on to finance legal actions against companies using our IT. We will see violations as this develops and it is almost guaranteed. Many companies both large and small will try to test our resolve, it is inevitable. I just hope they all make a fortune and end up paying us. Best case scenario is they just pay us up front and go to market soon.
Yep, they don't like to see folks make money trading. Anything less than total commitment to Dr. Kim and INO is a crime. You buy and hold and forget making money near term. No tolerance at all for traders.
That's the key. Ebola will focus on the company and the pipeline will drive us forward big time. Just getting noticed will bring the big investors. Too much, too cheap, and ready to move.
I own shares because I listened to the company guidance back in 2009 and 2010. I added in 2012 all based on Tokman's quarterly updates and forecasts. There are several of us and we own more shares than some insiders. Some of our group have averaged down, one at 5, one at 8 and not sure about the rest. Think the tech will succeed and counting on Sony to make it happen. No faith that Tokman has what it takes to take it to the finish, but will be here to see it through. The patents are worth four bucks if we can get it in a product. I paid to see this company grow and prosper and make a difference in the CE space. I get to voice my opinion when I see this jerk still learning on my money and producing nothing after half a billion dollars of investor cash.
I also like picking small companies with huge potential and have others with game changing science as well as mvis. I think this is the worse run company I have ever owned and I have been in the market for many years. Retired at 58 on my investments and now at 72, I still enjoy picking a few spec plays. Not ready to sign off on this one, will still think Tokman is an amateur even if he gets a product to market.